Aaron Royston - Net Worth and Insider Trading
Aaron Royston Net Worth
The estimated net worth of Aaron Royston is at least $124 Million dollars as of 2024-12-29. Aaron Royston is the Director of Akero Therapeutics Inc and owns about 3,954,858 shares of Akero Therapeutics Inc (AKRO) stock worth over $112 Million. Aaron Royston is also the Director, 10% Owner of Ventyx Biosciences Inc and owns about 5,011,536 shares of Ventyx Biosciences Inc (VTYX) stock worth over $12 Million. Details can be seen in Aaron Royston's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aaron Royston has not made any transactions after 2021-10-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aaron Royston
Aaron Royston Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aaron Royston owns 5 companies in total, including VYNE Therapeutics Inc (VYNE) , Akero Therapeutics Inc (AKRO) , and Elevation Oncology Inc (ELEV) among others .
Click here to see the complete history of Aaron Royston’s form 4 insider trades.
Insider Ownership Summary of Aaron Royston
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VYNE | VYNE Therapeutics Inc | 2019-06-25 | director |
| AKRO | Akero Therapeutics Inc | 2019-06-24 | director |
| ELEV | Elevation Oncology Inc | 2022-05-25 | 10 percent owner |
 | | 2021-10-25 | director & 10 percent owner |
| | 2023-09-14 | director |
Aaron Royston Latest Holdings Summary
Aaron Royston currently owns a total of 2 stocks. Among these stocks, Aaron Royston owns 3,954,858 shares of Akero Therapeutics Inc (AKRO) as of June 24, 2019, with a value of $112 Million and a weighting of 90.35%. Aaron Royston also owns 5,011,536 shares of Ventyx Biosciences Inc (VTYX) as of October 25, 2021, with a value of $12 Million and a weighting of 9.65%.
Latest Holdings of Aaron Royston
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AKRO | Akero Therapeutics Inc | 2019-06-24 | 3,954,858 | 28.25 | 111,724,739 |
| VTYX | Ventyx Biosciences Inc | 2021-10-25 | 5,011,536 | 2.38 | 11,927,456 |
Holding Weightings of Aaron Royston
Aaron Royston Form 4 Trading Tracker
According to the SEC Form 4 filings, Aaron Royston has made a total of 0 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years. The most-recent trade in Akero Therapeutics Inc is the acquisition of 250,000 shares on June 24, 2019, which cost Aaron Royston around $4 Million.
According to the SEC Form 4 filings, Aaron Royston has made a total of 1 transactions in Ventyx Biosciences Inc (VTYX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ventyx Biosciences Inc is the acquisition of 312,500 shares on October 25, 2021, which cost Aaron Royston around $5 Million.
Insider Trading History of Aaron Royston
- 1
Aaron Royston Trading Performance
GuruFocus tracks the stock performance after each of Aaron Royston's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aaron Royston is -8.16%. GuruFocus also compares Aaron Royston's trading performance to market benchmark return within the same time period. The performance of stocks bought by Aaron Royston within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aaron Royston's insider trading performs compared to the benchmark.
Performance of Aaron Royston
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.56 | | | | | |
| Relative Return to S&P 500(%) | 10.82 | | | | | |
Aaron Royston Ownership Network
Aaron Royston Owned Company Details
What does VYNE Therapeutics Inc do?
Who are the key executives at VYNE Therapeutics Inc?
Aaron Royston is the director of VYNE Therapeutics Inc. Other key executives at VYNE Therapeutics Inc include Chief Legal Officer and GC Mutya Harsch , 10 percent owner Perceptive Life Sciences Master Fund Ltd , and Interim CFO Tyler Zeronda .
VYNE Therapeutics Inc (VYNE) Insider Trades Summary
Over the past 18 months, Aaron Royston made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 13,000 shares made by Patrick G Lepore ,
In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 13,000 shares were bought by its insiders, resulting in a net purchase of 13,000 shares.
VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
VYNE Therapeutics Inc Insider Transactions
Aaron Royston Mailing Address
Above is the net worth, insider trading, and ownership report for Aaron Royston. You might contact Aaron Royston via mailing address: 200 Cardinal Way, 2nd Floor, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
